Shedding light on stem cells
COEUR d’ALENE — Dr. Joanne Halbrecht, medical director of CDA Orthopedics and Sports Medicine, has published two papers in the prestigious Journal of Bone and Joint Surgery about stem cell clinic ethics and misinformation.
“The concept for these papers was borne four years ago out of frustration with the website content of practitioners offering what they call ‘stem cell therapy,’” Dr. Halbrecht said. “It was clear that those who are not surgeons try to create fear of surgical complications or lack of trust in surgeons to convince patients to receive unproven and in many cases, illegal therapies, making wild promises to ‘grow a new joint,’ prevent the need for ever having surgery, or promising ‘100% success.’”
She and co-authors analyzed 900 stem cell clinic websites and found that 96% of clinics gave misinformation.
“While there are many studies showing promising results using biologics or cell therapy such as bone marrow, platelet-rich plasma and fat for orthopedic injuries and pain, many practitioners are using substances that are not FDA compliant and making unfounded claims of efficacy.”
In her articles, Dr. Halbrecht provides recommendations for practitioners and patients on the legal, ethical and FDA-compliant use and indications of cell therapy.
“Unfortunately, since insurance does not cover these therapies, practitioners have a huge financial incentive that has resulted in widespread misinformation that is meant to influence the consumer to purchase this treatment,” she said. “The consumer needs to be aware that while many of these treatments comply with FDA regulations and are backed by clinical studies, some are illegal and practitioners are making unfounded claims to promote these therapies.”
To read Dr. Halbrecht’s articles, see:
https://bit.ly/2tcDI6W
https://bit.ly/2GBqS5k